Blood Coagulation Disease

The gene therapy Casgevy, which will now be offered to some patients in England, could help people live disease-free, experts say.

Six CAR-T-cell therapies have been approved by the European Commission and the US FDA, and other T-cell therapies are being developed.

Drug may potentially 'transform' approach to upfront treatment, investigator says

New research reveals that fibrin, a key component of blood clots, may be the secret culprit behind the devastating neurological and inflammatory aftermath of the virus, including Long COVID. From dense, stubborn clots to brain fog, the interaction of COVID's spike protein with fibrin could be the missing link—and a potential target for life-saving therapies.

Research builds on growing evidence that the sweetener erythritol may not be safer than sugar after all.

The cutaneous manifestations of Munchausen syndrome by proxy are complex, but pediatric dermatologists can play an important role in their identification.

Here's everything you need to know to choose the best omega-3 fish oil supplements for you, including vegan options.

Documents examined by inquiry show officials knew people were being given infected blood products, but sanctioned their use

The Food and Drug Administration on Friday approved Pfizer's treatment for a rare genetic bleeding disorder, making it the company's first-ever gene therapy ...

Pfizer reported a list price of $3.5 million for its new gene therapy, Beqvez, for adults with this rare bleeding disorder.

In lab-dishes studies, proteins drawn from tiny tardigrades slowed human cell metabolism.

Compared with controls, women with heavy menstrual bleeding were more likely to have received their last dose of mRNA vaccine in the previous 1-3 months in a recent study.

The king brown snake, also known as the mulga, occupies many regions of Australia and is partial to the most arid regions.

Menstruation stigma shapes the products we buy — and hurts our health.

This Emergency Use Authorization and CDC recommendation makes Novavax's vaccine the only protein-based non-mRNA COVID vaccine option in the U.S. Novavax expects doses will be available in...

It's less clear-cut for postmenopausal women, study authors say

All subtypes of dementia, irrespective of patients' previous dementia types, behaved like rapidly progressive dementia following COVID-19, according to the Journal of Alzheimer's Disease Reports Infection with SARS-CoV-2 has a significant impact on cognitive function in patients with preexisting

There's so much more to the field than most people realize

The US Food and Drug Administration on Tuesday approved Hemgenix, a new drug to treat hemophilia. Manufacturer CSL Behring set the price at $3.5 million per treatment, making it the most expensive drug in the world.

Hemgenix reduced rate of annual bleeds, eliminated need for factor IX prophylaxis therapy